Stock Catalyst AI
VIP Login VIP €10

Signal #145604 · SEC 8-K

$MTVA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

← All archive signals

FAQ: $MTVA filing catalyst

Why did $MTVA trigger an AI stock catalyst alert?

$MTVA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +7.5/10). Headline: MetaVia DA-1726 Phase 1 Data Shows 68% Liver Fat Reduction and 13.5% Weight Loss. Key points: - DA-1726 achieved statistically significant 68% placebo-adjusted liver fat reduction (p<0.001) in Phase 1 Part 3B interim data. - Demonstrated 13.5% placebo-adjusted weight loss and HbA1c reduction to 5.33% with no study-discontinuing GI adverse events. - Full Part 3A and Part 3B study data anticipated in 2027.

How did $MTVA stock react after the SEC filing?

After the SEC 8-K for $MTVA, observed market reaction: T0 price $1.34. Past moves do not guarantee future results.

Where can I get real-time $MTVA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $MTVA via Telegram and the VIP Web Terminal from €10/month.

$MTVA

$MTVA – MetaVia DA-1726 Phase 1 Data Shows 68% Liver Fat Reduction and 13.5% Weight Loss

MetaVia Inc.
· SEC 8-K · All $MTVA

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+7.5 / 10)
  • DA-1726 achieved statistically significant 68% placebo-adjusted liver fat reduction (p<0.001) in Phase 1 Part 3B interim data.
  • Demonstrated 13.5% placebo-adjusted weight loss and HbA1c reduction to 5.33% with no study-discontinuing GI adverse events.
  • Full Part 3A and Part 3B study data anticipated in 2027.
Unlock Live VIP Terminal & Telegram – €10/mo Original filing →